Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases
Z Long, L Zeng, Q He, K Yang, W Xiang, X Ren… - Frontiers in …, 2023 - frontiersin.org
Autoimmune diseases are affected by complex pathophysiology involving multiple cell
types, cytokines, antibodies and mimicking factors. Different drugs are used to improve these …
types, cytokines, antibodies and mimicking factors. Different drugs are used to improve these …
Efficacy and safety of nintedanib in patients with connective tissue disease-interstitial lung disease (CTD-ILD): a real-world single center experience
M Boutel, A Boutou, G Pitsiou, A Garyfallos… - Diagnostics, 2023 - mdpi.com
Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD) is a severe and fatal
manifestation of systemic autoimmune disorders. Therapies rely on immunomodulators but …
manifestation of systemic autoimmune disorders. Therapies rely on immunomodulators but …
The additional treatment value of immunoglobulin for the treatment of rheumatoid arthritis complicated with interstitial lung disease: A propensity score‐matched pilot …
X Shen, F Wang - International Journal of Rheumatic Diseases, 2023 - Wiley Online Library
Objective To explore the additional treatment value of intravenous immunoglobulin
injections for treating interstitial lung disease (ILD) caused by rheumatoid arthritis (RA) …
injections for treating interstitial lung disease (ILD) caused by rheumatoid arthritis (RA) …
Clinical characteristics of patients with connective tissue disease–related interstitial lung disease: a retrospective analysis
S Colak, E Tekgoz, EC Gunes, N Ocal, D Dogan… - Clinical …, 2024 - Springer
Introduction Interstitial lung disease is one of the most critical manifestations of connective
tissue diseases that may cause morbidity and mortality. This study aimed to evaluate the …
tissue diseases that may cause morbidity and mortality. This study aimed to evaluate the …
Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis
M Hong, X Yin, W Yan, W Guo, H Liu… - Biomolecules and …, 2024 - bjbms.org
Connective tissue disease-associated interstitial lung disease (CTD-ILD) is an important
underlying cause of morbidity and mortality in patients with CTD. Serum Krebs von den …
underlying cause of morbidity and mortality in patients with CTD. Serum Krebs von den …
Praktikable Sjögren-Diagnostik bei interstitieller Lungenerkrankung–ein Diskussionsbeitrag
Zusammenfassung Das Sjögren-Syndrom (SjS) stellt eine mögliche autoimmune Ursache
einer interstitiellen Lungenerkrankung dar. Die Abklärung in Richtung SjS ist aber im …
einer interstitiellen Lungenerkrankung dar. Die Abklärung in Richtung SjS ist aber im …
[PDF][PDF] FACULTY OF HEALTH SCIENCES
MA Boutel - 2023 - ikee.lib.auth.gr
ABSTRACT Background Connective Tissue Interstitial Lung Disease (CTD-ILD) is a frequent
and severe manifestation of systemic autoimmune disorders leading to increased morbidity …
and severe manifestation of systemic autoimmune disorders leading to increased morbidity …
Practicable diagnostics of Sjögren's syndrome in interstitial lung disease-A discussion article
Abstract Das Sjögren-Syndrom (SjS) stellt eine mögliche autoimmune Ursache einer
interstitiellen Lungenerkrankung dar. Die Abklärung in Richtung SjS ist aber im Vergleich zu …
interstitiellen Lungenerkrankung dar. Die Abklärung in Richtung SjS ist aber im Vergleich zu …
Zanubrutinib ameliorates experimental idiopathic inflammatory myopathy-associated interstitial lung disease by BTK/NF-κB signaling pathway
Z Liu, Z Liu, W Li, Z Yang, L Meng, T Zhang, D Chai… - 2024 - researchsquare.com
Idiopathic inflammatory myopathy, abbreviated as myositis, is a heterogeneous disease
characterized by proximal muscle involvement and chronic inflammation, primarily affecting …
characterized by proximal muscle involvement and chronic inflammation, primarily affecting …